Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Stephan von Haehling

ResearcherPublications, citations & collaboration network

Stephan von Haehling is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 670 works, 43,271 citations, an h-index of 100 and an i10-index of 396.

670
Works
43,271
Citations
100
h-index
396
i10-index

How has Stephan von Haehling's publication output changed over time?

ScholarIQpublication output · 2007–2024

Output grew0% over the shown period — from 1 works in 2007 to 1 in 2024.

1
1
1
1
1
2
1
2
1
1
2007201020112012201320162019202020222024

What are the most-cited papers on Stephan von Haehling?

ScholarIQmost cited works
Frailty Consensus: A Call to Action
John E. Morley, Bruno Vellas, Gabor Abellán van Kan, Stefan D. Anker, Juergen M. Bauer, Roberto Bernabei, Matteo Cesari, Wm. Cameron Chumlea, Wolfram Doehner, Jonathan P Evans, Linda P. Fried, Jack M. Guralnik, Paul R. Katz, Theodore K. Malmstrom, Roger McCarter, Luis Miguel Gutiérrez‐Robledo, K. Rockwood, Stephan von Haehling, M. Vandewoude, Jeremy Walston
Journal of the American Medical Directors Association. 20134,122 Citations
Welcome to the ICD‐10 code for sarcopenia
Stefan D. Anker, John E. Morley, Stephan von Haehling
S173726759. 20161,166 CitationsOPEN ACCESS
Sarcopenia With Limited Mobility: An International Consensus
John E. Morley, Angela Marie Abbatecola, Josep M. Argilés, Vickie E. Baracos, Juergen Bauer, Shalender Bhasin, Tommy Cederholm, Andrew J.S. Coats, Steven R. Cummings, William J. Evans, Kenneth C.H. Fearon, Luigi Ferrucci, Roger A. Fielding, Jack M. Guralnik, Tamara B. Harris, Akio Inui, Kamyar Kalantar‐Zadeh, Bridget‐Anne Kirwan, Giovanni Mantovani, Maurizio Muscaritoli, Anne B. Newman, Filippo Rossi Fanelli, Giuseppe Rosano, Ronenn Roubenoff, Morris Schambelan, Gerald H. Sokol, Thomas W. Storer, Bruno Vellas, Stephan von Haehling, Shing-Shing Yeh, Stefan D. Anker
Journal of the American Medical Directors Association. 20111,133 CitationsOPEN ACCESS
An overview of sarcopenia: facts and numbers on prevalence and clinical impact
Stephan von Haehling, John E. Morley, Stefan D. Anker
S173726759. 2010893 CitationsOPEN ACCESS
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Alexander R. Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden‐Masley, Alain Cohen‐Solal, Carlo G. Tocchetti, Javid J. Moslehi, John D. Groarke, Jutta Bergler‐Klein, Vincent Khoo, Li Ling Tan, Markus S. Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G. Neilan, Yu. N. Belenkov, Stuart D. Rosen, Zaza Iakobishvili, Aaron L. Sverdlov, Ludhmila Abrahão Hajjar, Ariane Vieira Scarlatelli Macedo, Charlotte Manisty, Fortunato Ciardiello, Dimitrios Farmakis, Rudolf A. de Boer, Hadi Skouri, Thomas Suter, Daniela Cardinale, Ronald Witteles, Michael G. Fradley, Joerg Herrmann, Robert F. Cornell, Ashutosh Wechelaker, Michael J. Mauro, Dragana Milojković, Hugues de Lavallade, Frank Ruschitzka, Andrew J.S. Coats, Petar Seferović, Ovidiu Chioncel, Thomas Thum, Johann Bauersachs, María Sol Andrés, David J. Wright, Teresa López‐Fernández, Chris Plummer, Daniel J. Lenihan
European Journal of Heart Failure. 2020796 CitationsOPEN ACCESS

Related on ScholarIQ

Universitätsmedizin Göttingen
Institution
Frailty Consensus: A Call to Action
Paper
Welcome to the ICD‐10 code for sarcopenia
Paper
Sarcopenia With Limited Mobility: An International Consensus
Paper
An overview of sarcopenia: facts and numbers on prevalence and clinical impact
Paper
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Paper
470M+ articles · free account